R&D + Strategic Partnering
for the Global Vaccine Industry

Dominic Andrada is a Senior Manager for Scientific Applications in the LTG Marketing Group at Luminex Corporation. His professional career spans over 20 years intersecting product development, marketing, business development, and biopharma research. His focus is developing collaborations to utilize ...

Phyllis Arthur is Senior Vice President for Infectious Diseases and Emerging Science Policy at the Biotechnology Innovation Organization (BIO).  In this role Ms. Arthur is responsible for working with member companies in vaccines, antimicrobial resistance and biodefense on policy, legislative and...

Dr. Jay A. Berzofsky was appointed Chief, Vaccine Branch, Center for Cancer Research, National Cancer Institute, in 2003, after being Chief, Molecular Immunogenetics and Vaccine Research Section, since 1987. He graduated Summa cum Laude from Harvard (1967), and received a PhD-MD from Albert...

Alexandra Bhatti is a public health attorney with a decade of diverse vaccine programmatic and policy experience across the government and private sector. She is currently Director of US Vaccine Public Policy at Merck & Co. Inc, where she leads US state and federal vaccine policy development...

Graduated in medicine from the Pontifical Catholic University of São Paulo in São Paulo, Fernanda did a medical residency in neurology and a master's degree from the Federal University of São Paulo (Unifesp). She has 18 years of experience in healthcare and 12 years in the pharmaceutical...

Partner, NVG LLC.  Coalition manager extraordinaire, currently running the Adult Vaccine Access Coalition (AVAC) and managing the Infectious Disease Prevention Network (IDPN). Subject matter expert in vaccine policy, diabetes-related policy issues, and preventive health. Broad reach in the patient...

ShouBai CHAO, Chief Operating Officer(COO) and Executive Director of CanSino Biologics Inc. He is primarily responsible for the management of daily operations and strategy development. In addition, Dr. Chao also oversees production management and quality control. Dr. Chao has around 33 years of...

Dedicated to improving human health by leveraging innovations in biotechnology to fight disease. Tim has pursued this goal working in large and small companies and serving on advisory committees that shape national and global policies.

Dr. Crooke is the Lead Microbiologist for Vaccine Immunology in the Viral Vaccine Preventable Diseases Branch (VVPDB) at the Centers for Disease Control and Prevention. He is a member of the American Society for Virology and an investigator in the Center for Childhood Immunizations and Vaccines at...

Dr. Delese Mimi Darko holds a Doctorate Degree in Pharmacology and a Bachelor of Pharmacy from the Kwame Nkrumah University of Science and Technology (KNUST),and a master’s degree in Business Administration from the University of Northampton.With her over 32-years of experience in the field of food ...

Professor and Vice Chair of Research in the Department of Laboratory Medicine and Pathology at the University of Washington and Core Scientist in the Infectious Disease and Translational Medicine Unit of the Washington National Primate Research Center, Seattle, WA. Dr. Derdeyn uses human subjects...

Dr. Evans is the President, Chief Executive Officer and Co-Founder of Inimmune Corp. Dr. Evans is also Director of the Center for Translational Medicine at the University of Montana and a Research Professor in the Division of Biological Sciences. He has over 20 years’ experience in the...

Rebecca Gentile is an Associate Director in Merck’s Quality Division of Vaccine and Biological Stability.  She leads a team which provides global oversight of stability programs for biologics programs from Phase 3 development through the commercial life cycle.Ms. Gentile holds a B.S. degree in...

As a medical oncologist, Kyle saw first hand the devastating effects that serious disease can have on patients and their families. This is why, after completing medical school, residency, and fellowship, he dedicated his life’s work to finding better therapies for those who desperately need them. ...

Graduated from the Itajubá Medical School in 1989, Esper Georges Kallás completed his medical residency in Infectious Diseases at the São Paulo Municipal Civil Servant Hospital and a master's degree at the Federal University of São Paulo (Unifesp). Defended in 1996, his dissertation analyzed...

Wolfgang Leitner is the chief of the Innate Immunity Section of the Basic Immunology Branch/Division of Allergy, Immunology and Transplantation (DAIT), at the National Institute of Allergy and Infectious Diseases (NIAID/NIH). He oversees the NIAID Vaccine Adjuvant Program, and his section manages...

Dr. Ofer Levy is principal investigator, staff physician and the Director of the Precision Vaccines Program at Boston Children’s Hospital, Professor of Pediatrics at Harvard Medical School, and Associate Member of the Broad Institute of MIT and Harvard. The Precision Vaccines Program (PVP) is an...

Luciana has spent more than 15 years implementing global health and supply chain programs and leading data monitoring and evaluation efforts. With experience in the US, Europe and 16 countries in Africa, her work has focused on conducting new primary research and supporting the integration of...

PhD in industrial organic chemistry awarded at the University of Florence, Italy, in 2006. More than 15 years experience in the field of vaccines development, focusing her research on bacterial vaccines against AMR pathogens mainly affecting impoverished communities. Involved in the development of...

Dr. Lisa Morici is a tenured Professor in the Dept. of Microbiology and Immunology at Tulane University School of Medicine. Her research program focuses on the development of next generation vaccines and adjuvants for biodefense and emerging or re-emerging infectious diseases. Dr. Morici has...

Dr. Jomana Musmar serves as the Designated Federal Officer and Executive Director of the Presidential Advisory Council on Combating Antibiotic Resistant Bacteria--a US federal advisory committee addressing all issues related to AMR through a One Health approach. Dr. Musmar also serves as a Senior...

He holds a degree in Industrial Pharmacy from Faculdade Oswaldo Cruz, a specialist in Health Law from USP and in Business Management from ESPM. He has taken complementary courses in the area of biotechnology at North Caroline State University and Massachusetts Institute of Technology. He began his...

Dr. Daniel Salmon is a Professor in Global Disease Epidemiology and Control and the Director for the Institute for Vaccine Safety at Johns Hopkins Bloomberg School of Public Health. His primary research and practice interests are in optimizing the prevention of childhood infectious diseases through ...

Graduated in Pharmacy from the University of Brasília (UnB) and in History from the State University of Londrina (UEL), Gustavo is a specialist in Public Health from the State University of Maringá (UEM), Master in Pharmacology and Toxicology from the Oswaldo Cruz Foundation (Fiocruz) and doctoral...

Dr. Sardesai founded Geneos after building Inovio Pharmaceuticals into a Phase III cancer and infectious disease immunotherapy company serving as its Chief Operating Officer. He held positions of increasing responsibility after joining the company in 2006 where he helped formulate the company’s...

Emmett received his undergraduate degree in Biology from Harvard College in 1974 and a simultaneous M.A. in Biology. He received MD and PhD degrees having attended medical school and graduate school at the Duke University School of Medicine from 1975 to 1981. He completed internship, residency and...

Dr. Alessandro Sette has devoted more than 35 years of study towards understanding the immune response, measuring immune activity, and developing disease intervention strategies against cancer, autoimmunity, allergy, and infectious diseases. The laboratory is defining in chemical terms the specific ...

Lora Shimp is the Director of JSI's international Immunization Center. She has worked at JSI since 1997 as a senior immunization technical expert and specialist in communication and behavior change, providing technical support at global and regional levels and directly in over 30 countries...

Dr. Smith is the Founder, President, and Principal Investigator of VRG/NOCCR, the AMR Knoxville and New Orleans locations.  He is also the CEO of Alliance for Multispecialty Research, LLC (AMR) and its 26 locations across the US. Dr. Smith has been involved as a Principal Investigator for 40 years...

Walter Straus serves as Vice President and Clinical Safety Lead at Moderna Therapeutics. In this capacity, his team leads safety assessment for the company’s COVID-19 vaccine program, from clinical development through post-authorization responsibilities globally. Prior to joining Moderna in...

Dr. Sumner leads INOVIO’s clinical-stage pipeline of DNA medicines, global clinical development, clinical operations and biostatistics efforts, as well as regulatory affairs, pharmacovigilance and medical affairs. Dr. Sumner previously served as CMO of Orexo AB since 2013. He previously held...

Dr. Tomaras is the Director of the Duke Center for Human Systems Immunology, Immunological Sciences and Director of the Duke Center for AIDS Research. She is one of the leaders in the international, multi-institutional HIV Vaccine Trials Network focused on discovery clinical trials in humans to...

Vandenberg D&B, short for Data and Bio, was founded to help companies navigate the borders between vaccine / immune technology and data science. We offer strategic advice on data science strategy, from analysis to processes, and translational science. Our customers are vaccine and biotech...

Dr. Wolfe currently serve as the Branch Chief for the Vaccine Program in support of the CBRN Division of the Biomedical Advanced Research and Development Authority (BARDA). In doing so, he leads the advanced development and management of complex vaccine projects targeting biological threats. The...

Richard joined CARB-X following almost 20 years in large pharma Infection R&D teams followed by 4 years at a small antibacterial biotech company where he supported the progression of small molecule compounds from discovery through to late-stage clinical development and registration.  He...

May Guo is the Chief Commercial Officer for Synthgene, a company dedicated to develop and manufacture novel and high quality starting materials for mRNA, gRNA, siRNA and oligos. Prior to Synthgene, May worked for Arranta Bio, TriLink, Synthego, Agilent and Promega in various business development...

Dr. Newman has more than 30 years’ experience in the biotechnology sector serving in senior management roles at GeoVax (Atlanta, GA), PaxVax (San Diego, CA), Pharmexa (Horsholm, Denmark), Epimmune (San Diego, CA), Vaxcel (Atlanta, GA), Apollon (Philadelphia, PA) and Cambridge Biotech (Boston, MA)...

Received PhD in Chemical & Biochemical Engineering from University of Iowa, USA followed by 30 yr professional career in leading Biotech companies in the areas of Technical Operations such as process & product development, clinical & commercial manufacturing of multiple classes of...